Safety and Efficacy of Benefix in Patients With Hemophilia B in Usual Care Settings in China
Status:
Completed
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this post-approval study is to evaluate the safety and efficacy of Benefix in
subjects with hemophilia B in usual care settings in China.